Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with COVID-19 in the United States from the hospital perspective
Subject/Therapeutic Area: COVID-19
Journal/Conference: Journal of Medical Economics
Author(s): Kilcoyne, A.; Jordan, E.; Zhou, A.; Thomas, K.; Pepper, A.N.; Chappell, D; Amarapala, M.; Hughes, A.; Thompson, M.
Economic analysis of n-butyl cyanoacrylate compared with ethylene vinyl alcohol copolymer liquid embolic embolization of brain arteriovenous malformations (bAVMs) from a US hospital perspective
Subject/Therapeutic Area: Brain
Journal/Conference: Interventional Neuroradiology
Author(s): Sudhakar R. Satti , Emilie Kottenmeier, Alia Khaled, George W.J. Wright and Heather L. Cameron
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer
Subject/Therapeutic Area: Oncology
Journal/Conference: Journal of Comparative Effectiveness Research
Author(s): Rugo, H. S., Haltner, A., Zhan, L., Tran, A., Bananis, E., Hooper, B., Mitra, D., & Cameron, C.
Outcomes of Image-guided Thermal Ablation (IGTA) and Stereotactic Body Radiation Therapy (SBRT) for Patients with Pulmonary Metastases: A Systematic Review and Meta-Analysis
Subject/Therapeutic Area: Lung Cancer
Journal/Conference: American College of Chest Physicians 2022
Author(s): Naghi A, Laeseke P, Ng C, Ferko N, Hall A, Wright GWJ, Zhang Y, Kalsekar I, Laxmanan B, Ghosh SK, Zhou M, Szapary P, Pritchett M
Overall Survival Associated with Image-guided Thermal Ablation (IGTA) and Stereotactic Body Radiation Therapy (SBRT) for patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Regression Analysis
Subject/Therapeutic Area: Lung Cancer
Journal/Conference: American Thoracic Society (ATS) international conference 2022
Author(s): Laeseke P, Ng C, Ferko, N, Naghi, A, Wright G, Zhang Y, Kalsekar I, Laxmanan B, Ghosh S, Zhou M, Szapary P, Pritchett M
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
Subject/Therapeutic Area: Nervous System
Journal/Conference: Current Medical Research and Opinion
Author(s): Samjoo IA, Worthington E, Haltner A, Spin P, Drudge C, Cameron C, Brennan R, Dahlke F, Adlard N
Comparative Assessment of Ergonomic Experience Operating with Heads-Up Display and Conventional Surgical Microscope in Anterior-Segment Surgeons.
Subject/Therapeutic Area: Vision
Journal/Conference : Asia Pacific Association of Cataract & Refractive Surgeons 2021
Author(s): Pan, J S-M.; Ainslie-Garcia, M.; Ferko, N.; Cheng, H.; Weinstock, R.
Date of Publication: 2021
Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries in Asia-Pacific Region: A Comprehensive Literature Review
Subject/Therapeutic Area: Vision
Journal/Conference : Asia Pacific Association of Cataract & Refractive Surgeons 2021
Author(s): Dhariwal, M.; Cheng, H.; Duperrouzel, C.; Zhou, A.
An Umbrella Review Comparing Femtosecond Laser-Assisted Cataract Surgery Outcomes with Manual Cataract Surgery at Different Timepoints. compared with Conventional Preoperative Management: A Literature Review.
Subject/Therapeutic Area: Vision
Journal/Conference : American Society of Cataract and Refractive Surgeons 2021
Author(s): Henderson, B.; Ainslie-Garcia, M.; Ferko, N.; Hsiao, C.
Oncology drugs without Phase III data: Comparison of reimbursement recommendations issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)
Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy.
Systematic Literature Review of the Efficacy and Safety of Maintenance Therapies for Adults with Acute Myeloid Leukemia in Complete Remission who are Ineligible for Hematopoetic Stem Cell Transplant
Subject/Therapeutic Area: Oncology
Journal/Conference : European Hematology Association Annual Meeting
Author(s): Suero B, Cameron H, Thompson G, Ahmed M, Chen C
Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy
Subject/Therapeutic Area: Oncology
Journal/Conference : ISPOR EU 2021
Author(s): Ahmed, M.; Suero, S.; Cameron, H.; Chen, C.
Ozanimod for treatment of biologic-experienced patients with moderate-to-severe ulcerative colitis: Results from a systematic literature review and network meta-analyses
Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
Subject/Therapeutic Area: Cardiac
Journal/Conference: European Heart Journal - Quality of Care and Clinical Outcomes
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
Subject/Therapeutic Area: Oncology
Journal/Conference: The Breast
Author(s): Elizabeth M Salvo, Abril Oliva Ramirez, Jenilee Cueto, Ernest H Law, Aaron Situ, Chris Cameron, Imtiaz A Samjoo
Matching-Adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline PASI from week 4-40
Comparative Effectiveness of Guselkumab in Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis
Subject/Therapeutic Area: Psoriatic Arthritis
Journal/Conference: Rheumatology
Author(s): Philip J. Mease, Iain B. McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D. Chakravarty, Anna Parackal, Chetan S. Karyekar, Sandhya Nair, Wolf-Henning Boehncke, Christopher Ritchlin
Cost effectiveness of Ofatumumab in Comparison With Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada